Using Drosophila models of neurodegenerative diseases for drug discovery

By Newman Tracey   Sinadinos Christopher   Johnston Alex   Sealey Megan   Mudher Amrit  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 2, 2011-02 ,pp. : 129-140

Informa Healthcare

Access to resources Recommend Favorite

Implications of Parkinson's Disease Pathophysiology for the Development of Cell Replacement Strategies and Drug Discovery in Neurodegenerative Diseases

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 7, 2012-11 ,pp. : 907-920

Bentham Science Publishers

Access to resources Recommend Favorite

Computer Aided Drug Design Studies in the Discovery of Secondary Metabolites Targeted Against Age-Related Neurodegenerative Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 21, 2015-01 ,pp. : 2239-2252

Bentham Science Publishers

Access to resources Recommend Favorite

Multi-Target Drug Design Approaches for Multifactorial Diseases: From Neurodegenerative to Cardiovascular Applications

By  

Current Medicinal Chemistry, Vol. 21, Iss. 24, 2014-08 ,pp. : 2743-2787

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Discovery and Target Validation

By  

Cells Tissues Organs, Vol. 169, Iss. 3, 2001-06 ,pp. : 265-271

Karger

Access to resources Recommend Favorite